Racial disparities in chemotherapy administration for early-stage breast cancer: a systematic review and meta-analysis Angela K. GreenEmeline M. AvikiVictoria Blinder Review 09 August 2018 Pages: 247 - 263
Neoadjuvant therapy for breast cancer treatment: an expert panel recommendation from the Brazilian Society of Breast Surgeons 2018 Fernanda Barbosa C RochaAna Beatriz FalconeAntonio Luiz Frasson Review 11 August 2018 Pages: 265 - 272
Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study Sae Byul LeeSeung Sang KoByung Ho Son Preclinical study 07 August 2018 Pages: 273 - 282
The prognostic value of androgen receptors in breast cancer subtypes Maria Ryssdal KrabyMarit VallaAnna Mary Bofin Preclinical study 14 August 2018 Pages: 283 - 296
Fluidic shear stress increases the anti-cancer effects of ROS-generating drugs in circulating tumor cells Sagar RegmiTo Sing FungKathy Qian Luo Preclinical study 16 August 2018 Pages: 297 - 312
Co-expressed genes enhance precision of receptor status identification in breast cancer patients Michael KennDan Cacsire Castillo-TongWolfgang Schreiner Preclinical study Open access 16 August 2018 Pages: 313 - 326
Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform Natalie C. WuWendy WongMichael F. Press Preclinical study Open access 17 August 2018 Pages: 327 - 338
Somatic EP300-G211S mutations are associated with overall somatic mutational patterns and breast cancer specific survival in triple-negative breast cancer Vahid BemanianJohn Christopher NooneJürgen Geisler Preclinical study 21 August 2018 Pages: 339 - 351
Therapeutic predictors of neoadjuvant endocrine therapy response in estrogen receptor-positive breast cancer with reference to optimal gene expression profiling Lisa Goto-YamaguchiMutsuko Yamamoto-IbusukiHirotaka Iwase Preclinical study 27 August 2018 Pages: 353 - 362
Gray matter density reduction associated with adjuvant chemotherapy in older women with breast cancer Bihong T. ChenTaihao JinArti Hurria Clinical trial Open access 07 August 2018 Pages: 363 - 370
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer Adrienne E. BorrieRhiannon V. RoseRichard B. Kim Clinical trial 09 August 2018 Pages: 371 - 379
A comparison of the imaging features of pleomorphic and classical invasive lobular carcinoma Phey Ming YeapAndrew EvansSarah J. Vinnicombe Clinical trial 09 August 2018 Pages: 381 - 389
Predicting efficacy of epirubicin by a multigene assay in advanced breast cancer within a Danish Breast Cancer Cooperative Group (DBCG) cohort: a retrospective-prospective blinded study Anna Sofie Kappel BuhlTroels Dreier ChristensenPeter Buhl Jensen Clinical trial Open access 11 August 2018 Pages: 391 - 400
Genetic polymorphisms of 3′-untranslated region of SULT1A1 and their impact on tamoxifen metabolism and efficacy A. B. Sanchez-SpitmanV. O. DezentjéHenk-Jan Guchelaar Clinical trial Open access 17 August 2018 Pages: 401 - 411
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG) Anouk K. M. ClaessensMonique E. M. M. BosThe Dutch Breast Cancer Research Group (BOOG) Clinical trial 18 August 2018 Pages: 413 - 423
Prognostic impact of skeletal muscle volume derived from cross-sectional computed tomography images in breast cancer Eun Jin SongChan Wha LeeEun Sook Lee Clinical trial 21 August 2018 Pages: 425 - 436
Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancer Soo Youn BaeSeok Jin NamSeung Pil Jung Clinical trial 21 August 2018 Pages: 437 - 444
Impact of primary breast cancer therapy on energetic capacity and body composition Tarah J. BallingerAnurag ReddyJeffrey S. Sledge Clinical trial Open access 22 August 2018 Pages: 445 - 452
Associations of preoperative breast magnetic resonance imaging with subsequent mastectomy and breast cancer mortality Shi-Yi WangJessica B. LongCary P. Gross Epidemiology 11 August 2018 Pages: 453 - 461
Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines Anand K. NarayanElena B. ElkinElizabeth A. Morris Epidemiology 20 August 2018 Pages: 463 - 468
NRF1 motif sequence-enriched genes involved in ER/PR −ve HER2 +ve breast cancer signaling pathways Jairo RamosJayanta DasDeodutta Roy Epidemiology 20 August 2018 Pages: 469 - 485
Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI Janice S. SungAdriana D. CorbenMalcolm C. Pike Epidemiology 23 August 2018 Pages: 487 - 496
Substantial evidence for the clinical significance of missense variant BRCA1 c.5309G>T p.(Gly1770Val) Emma TudiniSetareh MoghadasiConxi Lazaro Brief Report 13 August 2018 Pages: 497 - 503
The association between estrogen receptor alpha gene rs746432 polymorphism and the risk of breast cancer Bei WangFenlai Yuan Letter to the Editor 21 August 2018 Pages: 505 - 505
Pure or mixed-type classical invasive lobular carcinoma might show different imaging features Kadri Altundag Letter to the Editor 22 August 2018 Pages: 507 - 507
Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases Kadri Altundag Letter to the Editor 24 August 2018 Pages: 509 - 509
Re: Elevated BMI might more significantly affect the outcome negatively in luminal type breast cancer patients with brain metastases Brittany A. SimoneKevin KoNicole L. Simone Rebuttal Letter 27 September 2018 Pages: 511 - 511